John D. Archbold Memorial Hospital

Thomasville, Georgia 31799

0 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, COVID-19, COVID-19 Pulmonary Complications, Follicular Lymphoma, Metastatic Breast Cancer, Patients Undergoing Repeat Peripheral Artery Revascularization, SARS-CoV2 Infection

Studies at this site

• Roll-over Study to Allow Continued Access to Ribociclib — Running, not enrolling
• Gedatolisib Plus Fulvestrant With or Without Palbociclib vs Standard-of-Care for the Treatment of Patients With Advanced or Metastatic HR+/HER2- Breast Cancer (VIKTORIA-1) — Running, not enrolling
• Safety and Preliminary Efficacy Study of an Anti-inflammatory Therapeutic Antibody in Reducing Restenosis. — Completed
• Covid-19 Infection and Pulmonary Distress Treatment With Zanubrutinib in Hospitalized Participants — Completed
• Expanded Access Treatment Protocol: Remdesivir (RDV; GS-5734) for the Treatment of SARS-CoV2 (CoV) Infection (COVID-19) — APPROVED_FOR_MARKETING
• A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06) — Completed